Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
about
Low density lipoprotein cholesterol is inversely correlated with abdominal visceral fat area: a magnetic resonance imaging studyLipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesCoronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohortsDifferential network analysis with multiply imputed lipidomic dataIs prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.A case study of normalization, missing data and variable selection methods in lipidomics.Digital thermal monitoring (DTM) of vascular reactivity closely correlates with Doppler flow velocity.Using apolipoprotein B to manage dyslipidemic patients: time for a change?Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary diseaseNew automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of AtherosclerosisTrends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease statusDyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentPrevalence, Predictors, and Impact of Low High-Density Lipoprotein Cholesterol on in-Hospital Outcomes Among Acute Coronary Syndrome Patients in the Middle East.Lipid-related residual risk and renal function for occurrence and prognosis among patients with first-event acute coronary syndrome and normal LDL cholesterolAssociation of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes.Temporal trends in lipid screening and therapy among youth from 2002 to 2012Distinct Patterns of Association of Variants at 11q23.3 Chromosomal Region with Coronary Artery Disease and Dyslipidemia in the Population of Andhra Pradesh, India.Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary InterventionNanomedicines for Endothelial Disorders.The importance of functional tests in personalized medicine.Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification.Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review.Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid PatientsFood consumption and the actual statistics of cardiovascular diseases: an epidemiological comparison of 42 European countriesEffects on coronary atherosclerosis by targeting low-density lipoprotein cholesterol with statins.Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.The ezetimibe controversy: implications for clinical practice.Role of coronary artery calcium score and coronary CT angiography in the diagnosis and risk stratification of individuals with suspected coronary artery disease.Safety of inhibition of cholesteryl ester transfer protein with anacetrapib: the DEFINE study.PCSK9 Inhibitors: potential in cardiovascular therapeutics.HDL cholesterol and cardiovascular outcomes: what is the evidence?How low an LDL-C should we go with statin therapy?Potential contributions of intimal and plaque hypoxia to atherosclerosis.Primed Polymorphonuclear Leukocytes (PMNLs) from Hemodialysis Patients Enhance Monocyte Transendothelial Migration.Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.
P2860
Q21245697-385A17F3-3821-4728-85EB-4FC72A528F91Q26777871-C8A47B39-7E44-4C48-9F58-99678FF0A031Q26853571-3EB74D6B-2BB2-44C9-82A6-F77F73C6BDAAQ28686330-6E35AD90-EB3A-47C9-BFD7-4303D44E7BFFQ30000348-17FA4B0B-F96C-4A65-B720-8F1939581595Q30397875-E8E03BCC-8884-4713-8BFE-19E17341C185Q30847381-F5335107-37F6-466F-B42D-EE0B767FDCD3Q30958003-698581D5-6AD2-4637-AB73-6EA7EEBE0242Q33820011-D29D3AFD-1725-4995-AF5C-BFBE47FA647DQ33972551-64222CBC-0E7D-4324-88C8-41C6076DAF6AQ34351193-D2DDB0A3-4590-423F-B7E3-80B82DDA0584Q34412975-A1B4615E-664F-4241-A21A-F731C6378A38Q34487808-B7B41D1C-E4F3-407F-BE3D-6AF04E987BAAQ35029623-9B956AA1-EECF-4224-AC45-6C1A9D897EE6Q35228773-7C7AEF74-6265-41BB-93D8-95DB6CB47304Q35607759-B46CBDF7-769A-4ED5-9A21-154CD9129AC2Q35667553-C06E6722-F1C5-41A1-8564-A147ED40CB62Q36034652-6A61CB7A-FA40-418F-B206-8A06EEDE1626Q36039218-F35A1249-1421-4BF6-8D02-DCC18738BA57Q36165683-A325ED17-1630-4DAB-9202-A5637F69620CQ36530790-283CE52A-D7B1-4C26-AAC2-2B50A1C08FDBQ36651592-D65662E2-EC1E-4BA9-8033-13A6BE68AE11Q36919239-7E2C4AB0-DC52-467F-9236-60B0B6883B7DQ36958257-B0BAA121-C335-4081-8798-8C09767EDE80Q37007007-BF1C2600-706C-4A8D-B558-3BABE686A376Q37057113-61D0EB79-320A-49F6-BB3B-ADDCC39EB78EQ37132420-22B5075F-DF88-4C1D-9EEC-138AB9E7A1F8Q37293468-183D3358-4B6D-4C44-9BDE-2CFEDCD6E262Q37426672-E65AF13C-8308-4927-8BA7-95550DA4E43EQ37592818-71ED63EB-DE8A-4E3B-B711-92B40E01DF30Q37882523-A4538B99-B3AE-408B-BC46-ACBE68427807Q37884287-FF346CAC-5477-4311-B1EF-A7E193E425C0Q37885793-C9F651CB-EEF3-4755-941E-2BE1AA9E0265Q38048831-C9FD80F9-3C38-4B7E-B96C-13F224E61380Q38075818-BC159F37-CBF3-440D-A9AD-23CA9F753D16Q38082718-1F9FC797-5C64-4AF2-A84F-6F8763439944Q38176273-E0BE7F71-F21B-46E5-BDB1-9CAEC9AFE97AQ38422308-86DE068A-B529-4DB9-826A-B6315661DF14Q38646650-93071CDC-005E-4355-9152-6814EB025D7EQ39768278-9469F2FE-7974-44EF-8D93-20B56FEC992B
P2860
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Lipid levels in patients hospi ...... ns in Get With The Guidelines.
@en
Lipid levels in patients hospi ...... ns in Get With The Guidelines.
@nl
type
label
Lipid levels in patients hospi ...... ns in Get With The Guidelines.
@en
Lipid levels in patients hospi ...... ns in Get With The Guidelines.
@nl
prefLabel
Lipid levels in patients hospi ...... ns in Get With The Guidelines.
@en
Lipid levels in patients hospi ...... ns in Get With The Guidelines.
@nl
P2093
P50
P1476
Lipid levels in patients hospi ...... ns in Get With The Guidelines.
@en
P2093
Amit Sachdeva
Christopher P Cannon
Kenneth A Labresh
Prakash C Deedwania
P304
111-117.e2
P356
10.1016/J.AHJ.2008.08.010
P407
P577
2008-10-22T00:00:00Z